Target Corporation — Form 10-K Summary
Period clarification: The supplied filing is Target’s fiscal 2020 Form 10-K, for the 52 weeks ended January 30, 2021—not a 2019 fourth-quarter filing. Fiscal 2019 ended February 1, 2020.
Business context and reporting period
Target is a U.S.-focused, single-segment retailer selling general merchandise and food through stores and digital channels. Nearly all revenue is generated in the United States. The company operated 1,897 stores at year-end. Its stores also support digital fulfillment, including Order Pickup, Drive Up, and Shipt delivery.
Financial results and key metrics
| Metric | Fiscal 2020 | Fiscal 2019 |
|---|---|---|
| Total revenue | $93.6 billion | $78.1 billion |
| Operating income | $6.54 billion | $4.66 billion |
| Net earnings from continuing operations | $4.37 billion | $3.27 billion |
| Diluted EPS from continuing operations | $8.64 | $6.34 |
| Operating cash flow from continuing operations | $10.53 billion | $7.10 billion |
| Cash and cash equivalents at year-end | $8.51 billion | $2.58 billion |
- Revenue rose 19.8%; comparable sales increased 19.3%, with comparable digital-originated sales up 145%. Digital-originated sales represented 17.9% of sales, compared with 8.8% in 2019.
- Operating income increased 40.4%. The operating margin was 7.0%, up from 6.0%; GAAP diluted EPS increased 36.3%. Management’s non-GAAP adjusted diluted EPS was $9.42, versus $6.39.
- Gross margin rate declined to 28.4% from 28.9%, reflecting sales mix and higher digital fulfillment, supply-chain, pay, and benefit costs. Exceptionally low clearance and promotional markdowns partly offset those pressures. SG&A expense rate improved to 19.9% from 20.8% as sales growth more than offset higher expenses.
- Year-end inventory was $10.65 billion, up from $8.99 billion. Cash from operations rose 48.3%; capital expenditures were $2.65 billion.
- Long-term debt and other borrowings were $11.54 billion, with $1.14 billion classified as current. This balance includes finance lease liabilities; notes and debentures totaled $10.64 billion. Target had an undrawn $2.5 billion revolving credit facility, expiring in October 2023, and reported investment-grade debt ratings.
Material changes versus the prior comparable period
- COVID-19-related changes in consumer demand and shopping patterns drove unusually strong sales, particularly in food, household essentials, hardlines, and home. Apparel and accessories fell significantly early in the year, then recovered.
- Comparable sales growth reflected a 15.0% increase in average transaction amount and a 3.7% increase in transactions. Store-originated comparable sales rose 7.2%; digital-originated sales contributed 12.1 percentage points to comparable sales growth.
- Operating cash flow benefited from stronger operating performance and increased accounts payable and other operating liabilities. Target also reported higher inventory at year-end.
- Target issued $2.5 billion of notes in March 2020 to increase cash on hand, then repurchased $1.77 billion of debt before maturity for $2.25 billion, recording a $512 million loss. Net interest expense increased to $977 million from $477 million, primarily because of that loss.
- Share repurchases totaled $609 million, down from $1.52 billion in 2019; the program was suspended in March 2020 and the suspension lifted in November. Dividends paid totaled $1.34 billion.
Outlook, management commentary, risks, and unusual items
- Target expects approximately $4.0 billion of capital expenditures in fiscal 2021, including investment in remodels, new stores, supply-chain capacity, sortation centers, Pickup and Drive Up, and Ulta Beauty shop-in-shops. It planned 150 full-store remodels and 30–40 new stores. The filing does not provide clear fiscal 2021 revenue or earnings guidance.
- Management said the pandemic’s effects remain uncertain. Potential risks include reversal of pandemic-era demand, persistent lower-margin category mix, higher digital fulfillment costs, supply constraints, and continued spending on health and safety. Target reported more than $1 billion of 2020 investments in team member and guest well-being, health, and safety.
- Target recorded $226 million of purchase-order cancellation fees in cost of sales as it adjusted orders, particularly for apparel and accessories. Fiscal 2020 adjusted EPS excludes specified items, including the debt-extinguishment loss and store damage and inventory losses related to civil unrest, net of insurance recoveries.
- In February 2021, Target sold Dermstore for approximately $350 million, subject to adjustments, and expected a pretax gain exceeding $300 million in the first quarter of 2021. Dermstore represented less than 1% of consolidated revenue, operating income, and net assets.
- Key disclosed risks include competition and changing consumer preferences; execution and cost of digital fulfillment and technology investments; cyber, data privacy, and system disruption; vendor, supply-chain, trade, and labor issues; macroeconomic conditions; and the continuing effects of COVID-19. The company said identified ordinary-course claims and litigation were not expected to be material; specified Canada-related securities and ERISA class actions were concluded after dismissal.
- The auditor issued unqualified opinions on the financial statements and internal controls. Inventory valuation and vendor-income receivables were identified as critical audit matters. Management reported effective internal control over financial reporting.
Important facts for investors to verify
- Confirm the reporting-period mismatch: this is fiscal 2020, not a fiscal 2019 Q4 filing.
- Assess whether exceptional pandemic-era sales growth and digital demand persist, and whether Target can offset lower-margin mix and fulfillment costs.
- Review the composition and maturity profile of debt and finance leases, the $512 million early-retirement loss, and available liquidity.
- Track fiscal 2021 capital spending and the planned remodel, store-opening, and supply-chain investments against returns and execution.
- Monitor inventory valuation and vendor-income receivables, both highlighted as critical audit matters, as well as supply availability and markdown risk.
- Verify the realized proceeds and gain from the Dermstore sale and subsequent capital-allocation decisions, including dividends and share repurchases.